BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 7565764)

  • 1. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
    Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti MA
    Oncogene; 1998 Feb; 16(6):809-16. PubMed ID: 9488046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
    Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
    Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
    Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
    Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (TFG) as a novel SHP-1-interacting protein.
    Roccato E; Miranda C; Raho G; Pagliardini S; Pierotti MA; Greco A
    J Biol Chem; 2005 Feb; 280(5):3382-9. PubMed ID: 15557341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
    Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
    Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
    Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
    Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of rearrangement of TRK protooncogene in Chinese thyroid tumors.
    Kuo CS; Lin CY; Hsu CW; Lee CH; Lin HD
    Endocrine; 2000 Dec; 13(3):341-4. PubMed ID: 11216646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2).
    Nakagawara A; Liu XG; Ikegaki N; White PS; Yamashiro DJ; Nycum LM; Biegel JA; Brodeur GM
    Genomics; 1995 Jan; 25(2):538-46. PubMed ID: 7789988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.
    Pierotti MA; Bongarzone I; Borrello MG; Mariani C; Miranda C; Sozzi G; Greco A
    J Endocrinol Invest; 1995 Feb; 18(2):130-3. PubMed ID: 7629380
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic organization of the human NTRK1 gene.
    Greco A; Villa R; Pierotti MA
    Oncogene; 1996 Dec; 13(11):2463-6. PubMed ID: 8957089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic rearrangements of the NTRK1/NGF receptor.
    Pierotti MA; Greco A
    Cancer Lett; 2006 Jan; 232(1):90-8. PubMed ID: 16242838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma.
    Mencinger M; Panagopoulos I; Andreasson P; Lassen C; Mitelman F; Aman P
    Genomics; 1997 May; 41(3):327-31. PubMed ID: 9169129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
    Greco A; Miranda C; Pierotti MA
    Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8).
    Klugbauer S; Jauch A; Lengfelder E; Demidchik E; Rabes HM
    Cancer Res; 2000 Dec; 60(24):7028-32. PubMed ID: 11156407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.